Ipilimumab
CTLA-4-directed Blocking Antibody
Brands
Ipilimumab Injection
| Dosage | Brand | Image |
|---|---|---|
| 10 ML ipilimumab 5 MG/ML Injection | Generic | |
| 10 ML ipilimumab 5 MG/ML Injection [Yervoy] | Generic | |
| 40 ML ipilimumab 5 MG/ML Injection | Generic | |
| 40 ML ipilimumab 5 MG/ML Injection [Yervoy] | Generic |
Ipilimumab desired effects:
- Increased T Lymphocyte Activation
Ipilimumab drug classes:
- CTLA-4-directed Blocking Antibody
Ipilimumab pharmacologic actions:
- Antineoplastic Agents, Immunological
- Immune Checkpoint Inhibitors
Ipilimumab mechanism of action:
- CTLA-4-directed Antibody Interactions
